Overall Technical outlook

Price Summary

Concord Biotech Limited's stock, on 2025-08-14 opened at 1633.6, climbed to a high of 1658.8, dropped to a low of 1625.1, and closed up 0.54% at 1642.5, with 55589 shares traded.
Over the past year, the stock's highest price was 2601.1, and its lowest was 1386.7.
Analysts expect the price of CONCORDBIO to vary between 1600.0 and 1965.0, with an average expected price near 1840.0.

Technicals

Support and Resistance: The current price for CONCORDBIO is 1642.5, supported at 1604.1 with resistance at 1747.45. This indicates a trading range where 1604.1 might prevent further declines, while 1747.45 could hinder additional gains.
CONCORDBIO supportResistance 96cf08
Support/Resistance for CONCORDBIO


Aroon: The current reading of the AROON indicator suggests a neutral stance, with no clear signals indicating an upward or downward direction. This lack of directional bias suggests the market may be in a period of consolidation or uncertainty.
CONCORDBIO aroon 96cf08
Aroon chart for Concord Biotech Limited


Bol. Bands: The current reading of the BOLL BANDS is neutral, offering no clear signals for a movement in either direction. This suggests that the market may be in a holding pattern, with no dominant trend in place.
CONCORDBIO bbands 96cf08
Bolinger Bands chart for Concord Biotech Limited


Parabolic SAR: The PSAR has recently reversed from bearish to bullish, suggesting a possible upward trend. If this move is confirmed by other indicators, it could indicate a strong bullish signal. Investors may want to consider this as a potential opportunity, especially if additional trends support the PSAR's new direction.
CONCORDBIO psar 96cf08
Parabolic Stop and Reverse chart for Concord Biotech Limited


Stochastic: The current state of the STOCHASTIC is neutral, offering no clear signals of movement in either direction. This suggests a potential pause in market activity, with no strong trend emerging at the moment.
CONCORDBIO stoch 96cf08
Stochastic chart for Concord Biotech Limited


Tripple Moving Agerage: The current reading of the Tripple MOVING AVG is neutral, offering no clear signals for a movement in either direction. This suggests that the market may be in a holding pattern, with no dominant trend in place.
CONCORDBIO trippleSMA 96cf08
Tripple SMA chart for Concord Biotech Limited


When evaluating a company, it is crucial to examine its fundamentals, including its financial statements, management structure, and market position. Additionally, understanding the broader industry trends, competition, and regulatory landscape helps to create a well-rounded view. By assessing both the company's internal factors and the external environment in which it operates, you can extract more valuable insights from its technical performance, such as stock price movements and trading patterns.